At the same time, there is growing evidence that immune system dysfunction, particularly TLR4 signalling pathway dysfunction, plays a key role in the pathogenesis of IBD [34, 35] and that the development of IBD and the benefits of its treatment are both influenced by the TLR4 signalling pathway [36]. The gene discussed is TLR4; the disease is inflammatory bowel disease.